REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Clb Med Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Rental and Leasing Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | All Other Miscellaneous Schools and Instruction | Educational Support Services | Outpatient Care Centers | Other Personal and Household Goods Repair and Maintenance
Full name: Clb Med Sp. z o.o. Profile Updated: May 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Clb Med Sp. z o.o. is a company in Poland, with a head office in Lukow. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on February 03, 2016. 1 (2016) employees currently work for Clb Med Sp. z o.o.. A negative growth of 8.56% was recorded in its total assets.

Headquarters
Ul. Miedzyrzecka 66
Lukow; Lubelskie; Postal Code: 21-400

Contact Details: Purchase the Clb Med Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Clb Med Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Clb Med Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Clb Med Sp. z o.o. report to view the information.
Incorporation Date:
February 03, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
98.8%
Company Performance
Financial values in the chart are available after Clb Med Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-18.75%▼
Net Profit (Loss) for the Period
-18.75%▼
Total assets
-8.56%▼
Total equity
-5.3%▼
Return on Equity (ROE)
-1.13%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Selkis Sp. z o.o.
 
Auxilius Pharma Oncology Sp. z o.o.
Quantum Innovations Sp. z o.o.
 
Medonlive Sp. z o.o.
Lipolek Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo